$1b deal here were come, page-24

If you recall Buda, Oncolys (of China) had to give the TT-033 rights back due to the slow pace of progress after nearly three years. China had their chance to cure HCV and they took it nowhere.

Benitec also went to China in a hope of collaborating with the Chinese researchers on the pain program. They weren't interested.

Believe me, I hope you are right, but, for the moment, I prefer that PF is focused elsewhere.